FDA approves 1st drug for narcolepsy type 1
The FDA has approved Orzeyful (oveporexton) tablets to treat narcolepsy type 1 in adults, marking the first therapy approved to treat the full range of symptoms associated with the disorder and the first to target its underlying biological cause. Unlike existing treatments that address individual symptoms, Orzeyful restores orexin signaling by activating the same brain […] The post FDA approves 1st drug for narcolepsy type 1 appeared first on Becker's Hospital Review | Healthcare News...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.